Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.61 is in line with its 5-year average of 2.80, near the low end of its 5-year range (0.72–12.08).
As of the fiscal period ended Tuesday, June 30, 2026. 16.30% below its 12-month average of 3.12.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.61.
QUICK RATIO (ACID-TEST)
2.61
QUICK RATIO (ACID-TEST) AVG TTM
3.12
QUICK RATIO (ACID-TEST) AVG 3Y
2.47
QUICK RATIO (ACID-TEST) AVG 5Y
2.80
QUICK RATIO (ACID-TEST) AVG 10Y
1.62
QUICK RATIO (ACID-TEST) AVG 15Y
0.96
QUICK RATIO (ACID-TEST) AVG 20Y
0.25
CURRENT VS TTM AVG
-16.30%
CURRENT VS 3Y AVG
+5.68%
CURRENT VS 5Y AVG
-6.95%
CURRENT VS 10Y AVG
+60.96%
CURRENT VS 15Y AVG
+170.64%
CURRENT VS 20Y AVG
+929.55%
SECTOR MEDIAN · HEALTHCARE
2.99
median of 508 covered companies
CURRENT VS SECTOR MEDIAN
-12.76%
vs the sector median at left
GT Biopharma, Inc.
Market Cap
$7.96M
Quick Ratio (Acid-Test)
2.61
TTM Avg
3.12
3Y Avg
2.47
5Y Avg
2.80
Market Cap
$7.89M
Quick Ratio (Acid-Test)
5.86
TTM Avg
2.71
3Y Avg
2.06
5Y Avg
3.31
Market Cap
$7.61M
Quick Ratio (Acid-Test)
2.63
TTM Avg
4.46
3Y Avg
3.65
5Y Avg
4.69
Market Cap
$7.58M
Quick Ratio (Acid-Test)
1.37
TTM Avg
3.92
3Y Avg
4.12
5Y Avg
3.73
Market Cap
$8.42M
Quick Ratio (Acid-Test)
13.55
TTM Avg
6.32
3Y Avg
6.80
5Y Avg
6.83
Market Cap
$7.21M
Quick Ratio (Acid-Test)
45.95
TTM Avg
58.73
3Y Avg
40.89
5Y Avg
40.89
Market Cap
$7.00M
Quick Ratio (Acid-Test)
1.52
TTM Avg
3.93
3Y Avg
10.24
5Y Avg
10.80
Market Cap
$6.80M
Quick Ratio (Acid-Test)
16.20
TTM Avg
7.76
3Y Avg
4.60
5Y Avg
3.08
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | $7.96M | 2.61 | 3.12 | 2.47 | 2.80 |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.89M | 5.86 | 2.71 | 2.06 | 3.31 |
| Longeveron Inc. (LGVN)vs › | $7.61M | 2.63 | 4.46 | 3.65 | 4.69 |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.58M | 1.37 | 3.92 | 4.12 | 3.73 |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.42M | 13.55 | 6.32 | 6.80 | 6.83 |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.21M | 45.95 | 58.73 | 40.89 | 40.89 |
| KALA BIO, Inc. (KALA)vs › | $6.77M | 6.88 | 3.46 | 4.15 | 4.53 |
| Co-Diagnostics, Inc. (CODX)vs › | $7.00M | 1.52 | 3.93 | 10.24 | 10.80 |
| Aclarion, Inc. (ACON)vs › | $6.80M | 16.20 | 7.76 | 4.60 | 3.08 |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.85M | 10.21 | 3.61 | 3.34 | 4.20 |
Quick Ratio
2.61
Excludes inventory
Current Ratio
2.61
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.61 |
| 2026-03-31 | 3.69 |
| 2025-12-31 | 3.50 |
| 2025-09-30 | 2.70 |
| 2025-06-30 | 3.09 |
| 2025-03-31 | 0.73 |
| 2024-12-31 | 0.72 |
| 2024-09-30 | 1.45 |
| 2024-06-30 | 2.47 |
| 2024-03-31 | 2.15 |
| 2023-12-31 | 2.12 |
| 2023-09-30 | 3.15 |
| 2023-06-30 | 3.72 |
| 2023-03-31 | 4.89 |
| 2022-12-31 | 3.35 |
| 2022-09-30 | 4.15 |
| 2022-06-30 | 2.78 |
| 2022-03-31 | 2.86 |
| 2021-12-31 | 3.14 |
| 2021-09-30 | 9.13 |
| 2021-06-30 | 12.08 |
| 2021-03-31 | 7.62 |
| 2020-12-31 | 0.16 |
| 2020-09-30 | 0.03 |
| 2020-06-30 | 0.03 |
| 2020-03-31 | 0.01 |
| 2019-12-31 | 0.01 |
| 2019-09-30 | 0.02 |
| 2019-06-30 | 0.02 |
| 2019-03-31 | 0.01 |
| 2018-12-31 | 0.01 |
| 2018-09-30 | 0.09 |
| 2018-06-30 | 0.12 |
| 2018-03-31 | 0.57 |
| 2017-12-31 | 0.22 |
| 2017-09-30 | 0.98 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.01 |
| 2016-12-31 | 0.00 |
| 2016-09-30 | 0.01 |
| 2016-06-30 | 0.02 |
| 2016-03-31 | 0.00 |
| 2015-12-31 | 0.00 |
| 2015-09-30 | 0.00 |
| 2015-06-30 | 0.01 |
| 2015-03-31 | 0.03 |
| 2014-12-31 | 0.03 |
| 2014-09-30 | 0.06 |
| 2014-06-30 | 0.00 |
| 2014-03-31 | 0.01 |
| 2013-12-31 | 0.01 |
| 2013-09-30 | 0.00 |
| 2013-06-30 | 0.00 |
| 2013-03-31 | 0.00 |
| 2012-12-31 | 0.02 |
| 2012-09-30 | 0.01 |
| 2012-06-30 | 0.00 |
| 2012-03-31 | 0.02 |
| 2011-12-31 | 0.02 |
| 2011-09-30 | 0.06 |
| 2011-06-30 | 0.03 |
| 2011-03-31 | 0.01 |
| 2010-12-31 | 0.02 |
| 2010-09-30 | 0.05 |
| 2010-06-30 | 0.11 |
| 2010-03-31 | 0.11 |
| 2009-12-31 | 0.19 |
| 2009-09-30 | 0.06 |
| 2009-06-30 | 0.07 |
| 2009-03-31 | 0.06 |
| 2008-12-31 | 0.06 |
| 2008-09-30 | 0.06 |
| 2008-06-30 | 0.14 |
| 2008-03-31 | 0.51 |
| 2007-12-31 | 0.66 |
| 2007-09-30 | 0.73 |
| 2007-06-30 | 0.64 |
| 2007-03-31 | 0.44 |
| 2006-12-31 | 0.67 |
| 2006-09-30 | 0.89 |
| 2006-06-30 | 0.93 |
| 2006-03-31 | 1.01 |
| 2005-12-31 | 1.13 |
| 2005-09-30 | 7.91 |
| 2005-06-30 | 6.73 |
| 2005-03-31 | 5.72 |
| 2004-12-31 | 2.72 |
| 2004-09-30 | 0.44 |
| 2004-06-30 | 0.49 |
| 2004-03-31 | 0.71 |
| 2003-12-31 | 0.70 |
| 2003-09-30 | 0.65 |
| 2003-06-30 | 0.57 |
| 2003-03-31 | 0.87 |
| 2002-12-31 | 0.98 |
| 2002-09-30 | 1.21 |